Latest News
An international team has successfully deployed a Zika virus vaccine to target and kill human glioblastoma brain cancer stem cells.
A team of researchers have created a method of measuring how circulating tumor cells perform functions that drive cancer, such as producing matrix metalloproteases.
NICE have approved dabrafenib plus trametinib for the adjuvant treatment of resected stage III BRAF V600 mutation-positive melanoma in adults.
Journal Articles
In this review article from Future Oncology find out about the PACIFIC trial design as well as the future of immunotherapy combinations and biomarkers beyond PD-L1.
A new study, published in CNS Oncology estimates the survival benefit of adding tumor treating fields and temozolomide for newly diagnosed glioblastoma patients.
Immune checkpoint inhibitors revolutionized the treatment of non-small-cell lung cancer, although their costs are a limitation; find out more in this article from Immunotherapy.
Brain and neurologic
Zika vaccine yields promising results for treating glioblastoma
Has the secret of the immortality cancer switch been unlocked?
Breast
Vistusertib with paclitaxel shows promise for ovarian and lung cancer in early trial
Tamoxifen, SERMs and sustainable medicine: an interview with V. Craig Jordan & Balkees Abderrahman
Colorectal
Data-driven blood test could be a step towards personalized treatment for bowel cancer
Chemicals found in vegetables prevent colon cancer in mice
Colorectal cancer screening age to be lowered to 50 in England
Endocrine
Blood test could detect kidney cancer up to 5 years earlier
FDA approves first-in-class treatment for rare adrenal tumors
Gastrointestinal
A remarkable insight into the cancer journey of Barbara Moss
Conference Chair highlights: World Congress on Gastrointestinal Cancer
Genitourinary
NICE approves atezolizumab for advanced bladder cancer patients on the NHS
Breakthrough method to diagnose prostate cancer developed
Researchers uncover 80 potential ways of targeting prostate cancer
Gynecologic
Vistusertib with paclitaxel shows promise for ovarian and lung cancer in early trial
Head and neck
Diabetics face a higher risk of mouth cancer, with women more at risk
The importance of a multidisciplinary team in the care of head and neck cancer
The importance of sentinel lymph node biopsies in the diagnosis of head and neck cancer
Hematologic
Kymriah® is set to become the first CAR-T therapy available on the NHS
CAR T therapy Yescarta get EU green light but meets resistance from NICE
Increased risk of myeloid blood cancers in relatives of patients
Lung
Reasoning the effect of immunotherapy after chemoradiation in the PACIFIC trial
Lung squamous cell carcinoma: key molecular player discovered
Chinese regulators approve Alecensa® for NSCLC, hot on heels of FDA and EMA approvals
Pancreatic
ESMO WCGI: Study highlights first-line treatment variations for pancreatic cancer
ESMO WCGI: Adjuvant FOLFIRINOX new standard of care for pancreatic cancer
ASCO18: Preoperative chemoradiotherapy improves survival time for patients with pancreatic cancer
Prostate
Circulating tumor cells: researchers develop mechanism for characterizing function
Immunotherapy may be an effective therapy for prostate cancer with mismatch repair mutations
Hair loss gene could be exploited to improve cancer immunotherapy
Rare tumors
Osteoblastoma genetic marker shows promise for identifying aggressive tumors
Skin
NICE approves dabrafenib–trametinib for BRAF+ melanoma
Hair loss gene could be exploited to improve cancer immunotherapy
